The Portfolio Armor Substack

The Portfolio Armor Substack

Share this post

The Portfolio Armor Substack
The Portfolio Armor Substack
Trade Alert: Betting On A Biotech

Trade Alert: Betting On A Biotech

A microcap with a catalyst coming in a few weeks.

Portfolio Armor's avatar
Portfolio Armor
Jul 24, 2023
∙ Paid

Share this post

The Portfolio Armor Substack
The Portfolio Armor Substack
Trade Alert: Betting On A Biotech
1
Share

SOM stands for severe oral mucositis, a side effect of radiation treatment for head and neck cancers.

One From My Market Watchers Funnel

I keep a Twitter list of finance accounts which I’m constantly adding to and pruning. A lot of finance content is simply accounts repeating headlines, or otherwise not adding much value, but occasionally you find exceptions. One of those exceptions may be the account that wrote about the micro cap biotech we’re betting on today. According to his profile, he’s a PhD scientist, and his drill-down on this company’s drug candidate suggests he has a solid science background.

There’s an FDA decision pending on this company’s drug candidate in early August, and this amateur biotech analyst is bullish on it, so I am too.

Details below.

Keep reading with a 7-day free trial

Subscribe to The Portfolio Armor Substack to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Portfolio Armor
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share